Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 34.69
-0.19 (-0.54%)
At close: Feb 12, 2026
SHE:301258 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 75.96 | 16.41 | 112.18 | 177.31 | 120.2 | 141.05 |
Depreciation & Amortization | 48.5 | 48.5 | 56.64 | 51.87 | 46.11 | 33.58 |
Other Amortization | 1.82 | 1.82 | 0.74 | - | - | - |
Loss (Gain) From Sale of Assets | 0.93 | 0.93 | 0.39 | - | - | - |
Asset Writedown & Restructuring Costs | 18.77 | 18.77 | 2.64 | 5.92 | 4.25 | 2.34 |
Loss (Gain) From Sale of Investments | -29.44 | -29.44 | -24.97 | -2.82 | -4.24 | -6.63 |
Other Operating Activities | -38.79 | -2.81 | -2.68 | -24.7 | 3.11 | 0.69 |
Change in Accounts Receivable | -42.52 | -42.52 | 11.21 | -37.96 | -12.9 | -15.82 |
Change in Inventory | -0.61 | -0.61 | -34.24 | -57.81 | -11.22 | 9.88 |
Change in Accounts Payable | 39.89 | 39.89 | -27.35 | 27.34 | 49.22 | -15.3 |
Change in Other Net Operating Assets | - | - | - | 7.11 | 3.27 | 4.59 |
Operating Cash Flow | 70.64 | 47.07 | 94.77 | 151.19 | 199.73 | 166.85 |
Operating Cash Flow Growth | 34.66% | -50.33% | -37.32% | -24.30% | 19.71% | 10.83% |
Capital Expenditures | -163.6 | -105.31 | -41.62 | -50.11 | -80.75 | -65.69 |
Sale of Property, Plant & Equipment | 7.66 | 8.83 | 0.07 | 0.19 | 0.15 | 0.08 |
Cash Acquisitions | - | - | - | - | - | -0.14 |
Investment in Securities | 143.48 | -42.61 | 69.26 | -1,138 | 100 | -100 |
Other Investing Activities | 49.63 | 39.97 | 20.86 | 13.79 | 10.71 | 11.86 |
Investing Cash Flow | 37.18 | -99.12 | 48.56 | -1,174 | 30.12 | -153.88 |
Short-Term Debt Issued | - | - | - | - | 18.56 | - |
Total Debt Issued | - | - | - | - | 18.56 | - |
Short-Term Debt Repaid | - | - | - | -18.56 | - | - |
Long-Term Debt Repaid | - | -0.71 | -0.71 | -0.48 | - | - |
Total Debt Repaid | -0.71 | -0.71 | -0.71 | -19.04 | - | - |
Net Debt Issued (Repaid) | -0.71 | -0.71 | -0.71 | -19.04 | 18.56 | - |
Issuance of Common Stock | - | - | - | 1,024 | - | - |
Repurchase of Common Stock | -20.14 | -20.14 | - | - | - | - |
Common Dividends Paid | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 | -100.38 |
Dividends Paid | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 | -100.38 |
Other Financing Activities | -29.02 | - | - | -25.25 | - | - |
Financing Cash Flow | -58.14 | -75.83 | -53.88 | 942.79 | 18.13 | -100.38 |
Foreign Exchange Rate Adjustments | 1.49 | 2.87 | 0.6 | 27.23 | -4.65 | -2.27 |
Net Cash Flow | 51.16 | -125.01 | 90.05 | -52.93 | 243.33 | -89.68 |
Free Cash Flow | -92.96 | -58.25 | 53.15 | 101.08 | 118.98 | 101.16 |
Free Cash Flow Growth | - | - | -47.42% | -15.05% | 17.62% | 27.05% |
Free Cash Flow Margin | -21.15% | -13.56% | 10.86% | 17.79% | 22.81% | 21.21% |
Free Cash Flow Per Share | -1.03 | -0.64 | 0.58 | 1.17 | 1.73 | 1.47 |
Cash Income Tax Paid | 16.5 | 1.25 | 17.95 | 7.95 | -9.3 | 14.14 |
Levered Free Cash Flow | -35.77 | -61.95 | 35.51 | 29.37 | 86.31 | 65.84 |
Unlevered Free Cash Flow | -35.72 | -61.9 | 35.58 | 29.56 | 86.59 | 65.84 |
Change in Working Capital | -7.11 | -7.11 | -50.18 | -56.39 | 30.31 | -4.18 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.